Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients.
D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects; D001228:Aspergillosis / Q000401:mortality; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001379:Azathioprine / Q000009:adverse effects; D002675:Child, Preschool; D002908:Chronic Disease; D003928:Diabetic Nephropathies / Q000601:surgery; D005260:Female; D005921:Glomerulonephritis / Q000601:surgery; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009181:Mycoses; D009617:Nocardia Infections; D011183:Postoperative Complications; D011241:Prednisone / Q000009:adverse effects; D013997:Time Factors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001379:Azathioprine; D011241:Prednisone